MedPath

Association Between Mitochondrial DNA Content and Risk of Acute Leukemia

Completed
Conditions
Lymphoblastic Leukemia in Children
Interventions
Diagnostic Test: Relative copy number of mitochondrial DNA
Registration Number
NCT03595969
Lead Sponsor
Air Force Military Medical University, China
Brief Summary

Compelling epidemiological evidence indicates that alterations of mitochondrial DNA, including mutations and abnormal content of mitochondrial DNA (mtDNA), are associated with the initiation and development of acute lymphoblastic leukemia (ALL).The aim of this study was to explore association between mtDNA content in peripheral blood cells could be used as a risk predictor for ALL.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • 1.histological confirmed chronic lymphocytic leukemia; 2.preparing for chemotherapy; 3.no preoperative anticancer treatment.
Exclusion Criteria
  • 1.history of other malignancy; 2.blood transfusion within one month or prior bone marrow transplantation; 3.patients who reluctant to sign informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
acute leukemia groupRelative copy number of mitochondrial DNA150 patients were recruited, who have diagnosed with acute leukemia by bone marrow biopsy
Control groupRelative copy number of mitochondrial DNAThe 50 healthy controls without previous cancer history were recruited from individuals who visited investigator's hospital for physical examination during the same time period as the case enrollment.
Primary Outcome Measures
NameTimeMethod
Relative copy number of mitochondrial DNAFrom date of admission until the date of discharging from hospital, assessed up to 5 days

The ratio of mitochondrial DNA contents to hemoglobin contents was calculated for each sample from standard curves. After that, the ratio for each sample was normalized to a calibrator DNA in order to standardize between different runs, and then defined as the measurement of relative mtDNA contents.Relative expression of mtDNA were measured in young adults suffered from chronic lymphocytic leukemiawhen compared with control group.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Xiao-Fan Zhu

🇨🇳

Tianjin, Tianjin, China

© Copyright 2025. All Rights Reserved by MedPath